Table 2. Baseline characteristics of patients with endophthalmitis in 20G vs MIVS group.

Baseline characteristics		20 G (n = 40)	MIVS (n = 5)	Overall (n = 45)	p-value
Age	Less than 50 years	18 (45.0%)	4 (80.0%)	22 (48.9%)	0.172
	More than 50 years	22 (55.0%)	1 (20.0%)	23 (51.1%)
Sex	Male	26 (65.0%)	5 (100%)	31 (68.9%)	0.235
	Female	14 (35.0%)	0 (0.0%)	14 (31.1%)
Immune predisposition	None	16 (40.0%)	3 (60.0%)	19 (42.2%)
	Diabetes	19 (47.5%)	2 (40.0%)	21 (46.7%)	0.808
	Steroids (oral)	5 (12.5%)	0 (0.0%)	5 (11.1%)
Any infective foci	Tooth caries	1 (2.5%)	0 (0.0%)	1 (2.2%)
Intra-ocular surgery within 1 year prior to vitrectomy	Yes	4 (10.0%)	3 (60.0%)	7 (15.5%)	0.004
Indication for PPV	Vitrectomy for Vascular retinopathies	18 (45.0%)	2 (40.0%)	20 (44.4%)	0.832
	Vitrectomy for uveitis	6 (15.0%)	0 (0.0%)	6(13.3%)
	Vitrectomy for macular pathologies	4 (10.0%)	1 (20.0%)	5 (11.1%)	0.502
	Traumatic vitreous hemorrhage	1 (2.5%)	1 (20.0%)	2 (4.4%)	0.074
	ROP	1 (2.5%)	0 (0.0%)	1 (2.2%)
	RRD	8 (20.0%)	0 (0.0%)	8 (17.8%)
	Nucleus drop/ sub-luxated lens	2 (5.0%)	1 (20.0%)	3 (6.7%)	0.205
Procedure performed	Vitrectomy alone	25 (62.5%)	4 (80.0%)	29 (64.4%)	0.641
	Vitrectomy + anterior segment procedure combined	15 (37.5%)	1 (20.0%)	16 (35.5%)
Duration of Surgery (hrs)	≤2 hrs >2 hrs	21 (52.5%) 19 (47.5%)	4 (80.0%) 1 (20.0%)	25 (55.5%) 20 (44.4%)	0.362
No. of Sclerotomies	3	39 (97.5%)	5 (100%)	44 (97.8%)	1.000
	4	1 (2.5%)	0 (0.0%)	1 (2.2%)
Tamponade	No tamponade	22 (55.0%)	5 (100%)	27 (60.0%)	0.073
	Tamponade	18 (45.0%)	0 (0.0%)	18 (40.0%)
Lens status at closure	Phakic	17 (42.5%)	1 (20.0%)	18 (40.0%)	0.634
	Not Phakic	23 (57.5%)	4 (80.0%)	27 (60.0%)

PPV: Pars plan vitrectomy, Sx: surgery, ROP: retinopathy of prematurity, RRD: Rhegmatogenous retinal detachment, SOI: silicone oil, C3F8: Perfluropropane